SKI Market

Indian Indices

Nifty

26,046.95 148.40
(0.57%)

Sensex

85,213.36 -54.30
( -0.06%)

Bank Nifty

59,389.95 180.10
( 0.30%)

Nifty IT

38,274.75 177.75
( 0.47%)

Global Indices

Nasdaq

48,475.79 -249.23
(-0.51%)

Dow Jones

6,848.05 -73.95
(-1.07%)

Hang Seng

50,163.71 -672.84
(-1.32%)

Nikkei 225

9,668.36 -34.80
(-0.36%)

Forex

USD-INR

90.19 0.30
(0.34%)

EUR-INR

105.70 1.00
(0.96%)

GBP-INR

120.75 0.96
(0.80%)

JPY-INR

0.58 0.01
(0.91%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Norris Medicines Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524414

INE744C01029

-15.8200926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

15.95

EPS(TTM)

Face Value()

Div & Yield %

Back

jost`s engineering company ltd

Inventure Growth & Securities reports standalone net loss of Rs 1.16 crore in the September 2025 quarter

Nov 07,2025

Net loss of Inventure Growth & Securities reported to Rs 1.16 crore in the quarter ended September 2025 as against net profit of Rs 0.82 crore during the previous quarter ended September 2024. Sales declined 21.76% to Rs 9.06 crore in the quarter ended September 2025 as against Rs 11.58 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	9.06	11.58	-22
OPM %	-11.59	15.54	-
PBDT	-1.41	1.12	PL
PBT	-1.65	1.01	PL
NP	-1.16	0.82	PL

26,046.95 148.40 (0.57%)

85,213.36 -54.30 ( -0.06%)

59,389.95 180.10 ( 0.30%)

38,274.75 177.75 ( 0.47%)

48,475.79 -249.23 (-0.51%)

6,848.05 -73.95 (-1.07%)

50,163.71 -672.84 (-1.32%)

9,668.36 -34.80 (-0.36%)

90.19 0.30 (0.34%)

105.70 1.00 (0.96%)

120.75 0.96 (0.80%)

0.58 0.01 (0.91%)